Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Diabetes Diagnostics Market from 2024 to 2025?
The market for diabetes diagnostics has seen robust growth in the recent past. It is projected to expand from $25.39 billion in 2024 to $27.39 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.9%. Factors such as an increase in diabetes cases, a growing elderly population, a rise in sedentary behaviors, escalated use of less invasive diagnostic procedures, and an uptick in obesity rates have all contributed to the growth witnessed during the historic period.
What Is the Projected Market Size of the Diabetes Diagnostics Market?
The market size of diabetes diagnostics is predicted to witness robust growth in the coming years, reaching a valuation of $36.72 billion by 2029, accelerating at a Compound Annual Growth Rate (CAGR) of 7.6%. The progression in the prediction period can be associated with numerous factors including the increased usage of insulin pumps, advancements in diabetes-related technology, adoption of unhealthy lifestyle habits, heightening instances of type 1 and type 2 diabetes, and a growing healthcare infrastructure. Major trends expected during the forecast period encompass improvements in biosensor technology, technological advancements, developments in diagnostic technologies, the rise of personalized medicine and targeted therapies, and the introduction of advanced technologies in in vitro diagnostic products.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp
Who are the Major Competitors in the Diabetes Diagnostics Market Outlook?
Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.
What Is Fueling Growth in the Diabetes Diagnostics Market?
The rise in obesity rates is anticipated to accelerate the expansion of the diabetes diagnostics market. Obesity is characterized by the excessive accumulation of body fat, which poses a higher risk of various diseases, including diabetes and heart disease. The surge in obesity prevalence can be linked to sedentary lifestyles, high intake of processed and calorie-dense foods, genetic factors, and lack of physical activity. Diabetes diagnostics aid in managing obesity, detecting issues such as insulin resistance and glucose metabolism problems at an early stage and allowing for prompt interventions to avoid weight gain and associated health risks. For instance, the Centers for Disease Control and Prevention, a US government agency, reported in September 2023 that in 2022, the adult obesity rate was 35% or greater in 22 states, up from 19 states in 2021. Hence, the growing prevalence of obesity constitutes a major factor propelling the growth of the diabetes diagnostics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp
Which Diabetes Diagnostics Market Segments Are Growing the Fastest?
The diabetes diagnostics market covered in this report is segmented –
1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types
2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes
3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users
Subsegments:
1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters
2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices
3) By Lancets: Single-use Lancets, Multi-use Lancets
4) By Test Strips: Standard Test Strips, Smart Test Strips
5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters
Which Industry Trends Are Shaping the Future of the Diabetes Diagnostics Market?
Key businesses in the diabetes diagnostics industry are concentrating their efforts on creating novel products, such as tools for diagnosing gestational diabetes, in an attempt to broaden their product range and meet the rising need for early detection and management of diabetes during pregnancy. Medically, a gestational diabetes diagnostic tool pertains to medical instruments or tests used for identifying and tracking gestational diabetes in expectant mothers. This often incorporates blood glucose testing methods like the oral glucose tolerance test (OGTT) to evaluate how well their body manages sugar during gestation. For instance, Austria’s biotech firm DirectSens GmbH, released an innovative biosensor apparatus called the XpressGT RUO kit, in August 2024. This product has been created for identifying insulin resistance-related issues such as gestational diabetes, endometriosis, and liver disease. The kit facilitates swift results by measuring 2-hydroxybutyrate (2-HB) levels in the blood from veins, and it can be used with ordinary clinical analyzers. The objective of this innovative solution is to facilitate early diagnosis, with the potential to enhance the health outcomes for millions of patients across the globe.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report
Which Countries Are Leading the Diabetes Diagnostics Market?
North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167
This Report Delivers Insight On:
1. How big is the diabetes diagnostics market, and how is it changing globally?
2. Who are the major companies in the diabetes diagnostics market, and how are they performing?
3. What are the key opportunities and risks in the diabetes diagnostics market right now?
4. Which products or customer segments are growing the most in the diabetes diagnostics market?
5. What factors are helping or slowing down the growth of the diabetes diagnostics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model